lung cancer | |||||
新闻 | |||||
Identifying HER2 Mutations for T-DXd Use in NSCLC - Cancer Network Levy, MD, regarding treatment updates for patients with non–small cell lung cancer (NSCLC) with HER2 expression. Additionally, they focused on ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment